In terms of enhancing the antitumor activity of adriamycin, nobiletin inhibits Akt and Wnt/β-catenin signaling pathway by increasing GSK-3β activity, and leads to decreased lung cancer cells viability (Moon et al., 2018). Here, GSK3B is linked to lung cancer.